Anti-leukemia effects of Omipalisib in Acute Myeloid Leukemia: inhibition of PI3K-AKT-mTOR signaling and suppression of Mitochondrial Biogenesis

MLA

Liang-In Lin, et al. Anti-Leukemia Effects of Omipalisib in Acute Myeloid Leukemia: Inhibition of PI3K-AKT-MTOR Signaling and Suppression of Mitochondrial Biogenesis. May 2023. EBSCOhost, https://doi.org/10.21203/rs.3.rs-2854129/v1.

APA

Liang-In Lin, Chi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou, Jeng-Wei Lu, & Hsin-An Hou. (2023). Anti-leukemia effects of Omipalisib in Acute Myeloid Leukemia: inhibition of PI3K-AKT-mTOR signaling and suppression of Mitochondrial Biogenesis. https://doi.org/10.21203/rs.3.rs-2854129/v1

Chicago

Liang-In Lin, Chi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou, Jeng-Wei Lu, and Hsin-An Hou. 2023. “Anti-Leukemia Effects of Omipalisib in Acute Myeloid Leukemia: Inhibition of PI3K-AKT-MTOR Signaling and Suppression of Mitochondrial Biogenesis,” May. doi:10.21203/rs.3.rs-2854129/v1.